External Sales Representative for Seeds

Major scientific breakthrough increases crop yields by using the plant's own natural mechanisms. The Associated Press Sep 22, 2026, 4:02 AM In one of the largest biological field programs of its kind, EXORT(TM) technology has delivered consistent yield gains across major crops - rice, soybean, corn, cotton, vegetable and fruits - over multiple years and geographies. BASEL, Switzerland-(BUSINESS WIRE)-Sep 22, 2026- Farmers are under growing pressure to produce more food from the same land, while using resources more efficiently and reducing agriculture's environmental footprint. Syngenta today announces EXORT(TM) technology, a major scientific breakthrough that helps plants make better use of their own biology. In one of the largest biological field programs of its kind, EXORT(TM) technology has delivered consistent yield gains across major crops - rice, soybean, corn, cotton, vegetable and fruits - over multiple years and geographies. This new technology opens the door to a new generation of biological solutions that can help farmers grow bigger grains and more desirable vegetables and fruits, without changing their normal field routine. Applied at very small doses to the leaf, products with EXORT(TM) technology work with natural signals that plants already use to regulate biological processes, development, and response to changing conditions. For farmers, the potential is significant: more productive crops, better quality, and a practical way to support higher yields with lower impact. In one of the largest biological field programs of its kind, EXORT(TM) technology has delivered consistent yield gains across major crops - rice, soybean, corn, cotton, vegetable and fruits - over multiple years and geographies. The science behind EXORT(TM) technology is based on natural microRNAs - tiny molecules found in plants that help regulate how biological instructions are used. Natural microRNAs act like signals that help orchestrate biological processes; EXORT(TM) technology is designed to apply precisely selected naturally occurring microRNAs at field scale, helping crops optimize how they use their own resources. Camilla Corsi, Syngenta's Head of Crop Protection Research & Development, said: "What makes EXORT(TM) technology so exciting is that it translates a fundamental biological mechanism into a practical agricultural solution. Advances in genomics, bioinformatics and plant science now allow us to identify and apply beneficial natural microRNAs with unprecedented precision. This is a remarkable example of how breakthrough science can be harnessed to help crops perform at their best, while supporting more sustainable agriculture." Built on years of in-house research in the fast-growing scientific field of microRNAs - whose discovery transformed the field of biology and was recognized by the 2024 Nobel Prize in Physiology or Medicine - the first products based on EXORT(TM) technology are planned for launch from 2027. This will be followed by a phased introduction across approximately 20 countries and multiple crops over the next years. Syngenta believes EXORT(TM) technology has the potential to become a foundational platform for the next generation of biological solutions. Web Resources About Syngenta Syngenta is a leading science-based agricultural technology (AgTech) company, creating Breakthroughs for farmers, in every field(TM) to help meet the demands of modern agriculture. Using cutting-edge innovation and guided by its Sustainability Goal of higher yields with lower impact, Syngenta helps farmers to grow resilient, healthy crops that can feed a growing global population, while protecting and enhancing the planet. Syngenta employs more than 30,000 employees in over 90 countries and is part of Syngenta Group. It consists of two business units: Syngenta Crop Protection, headquartered in Switzerland, and Syngenta Seeds, headquartered in the United States. To find out more about how Syngenta creates breakthroughs for farmers around the world, read its stories and follow Armstrong on social media. Data protection is important to Armstrong. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR ("legitimate interest"). However, if you do not wish to receive further information about Syngenta, just send Armstrong a brief informal message and Armstrong will no longer process your details for this purpose. You can also find further details in its privacy statement. Syngenta's Cautionary Statement Regarding Forward-Looking Statements This document may contain forward-looking statements, which can be identified by terminology such as "believe," "anticipate," "expect," "intend," "plan," "will," "may," "should," "estimate," "predict," "potential," "continue" and similar expressions. Forward-looking statements include statements concerning Syngenta's future expectations, plans, prospects, objectives, performance or events, including statements attributed to individuals quoted in this document, whether or not they use such terminology. Such statements are based on current expectations, assumptions, estimates and projections and are subject to known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by them. They are not guarantees of future performance, and readers should not place undue reliance on them. For Syngenta, such risks and uncertainties include, amongst others, risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, refinancing risk, interest rate fluctuations and access to capital markets, compliance and remediation, evolving environmental and sustainability regulations, changes in agricultural policies or subsidy regimes, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climate change and extreme weather events, fluctuations in exchange rates and/or agricultural commodity prices, supply chain disruptions, including risks arising from single-source supply arrangements, geopolitical risks, trade restrictions, sanctions, and export controls, natural disasters, and cybersecurity incidents, data breaches, and failures or disruptions of information technology systems. Forward-looking statements speak only as of the date of this document. Except as required by applicable law, Syngenta undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, changed assumptions or otherwise. (C) 2026 Syngenta. Rosentalstrasse 67, 4058 Basel, Switzerland. Syngenta Media Relations [email protected] KEYWORD: EUROPE SWITZERLAND ASIA PACIFIC INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE AGRICULTURE RESEARCH NATURAL RESOURCES TECHNOLOGY AGRITECH OTHER TECHNOLOGY PUB: 09/22/2026 03:00 AM/DISC: 09/22/2026 03:02 AM You May Also Like

Syngenta files for Hong Kong IPO, aiming to raise at least $5 billion, sources say. Sep. 17, 2026 Swiss seeds and agrichemicals company Syngenta Group has confidentially filed for a Hong Kong initial public offering, aiming to raise at least $5 billion, according to three people with direct knowledge of the matter. The Basel-based company, controlled by Chinese state-owned Sinochem hopes to launch the offering as soon as the end of this year, or if not, early 2027, said two of the sources. Depending on the market response, the offering size could be up to $10 billion, the sources said. At that size, it would be Hong Kong's biggest IPO since 2010, according to LSEG data. Hong Kong's IPO market is booming, with initial public offerings and secondary listings raising $45.8 billion so far this year, compared with $24 billion in the same period last year, LSEG data showed. The exact timing, offering size and the company's valuation have not been finalised, said the sources, who declined to be named as the information was not public. A listing of that size would test investor appetite for a company whose owner, Sinochem, paid $43 billion to take it private in 2017 and has yet to mark that investment to a public market valuation. Success would hand Hong Kong one of its marquee deals of the year and give Syngenta a way to start paying down some of its debts and also invest in new crop-protection products and seeds. Syngenta expects the global agricultural market to improve next year, especially if there is a resolution in the Iran conflict that would ease shortages of natural gas used to make fertilisers, making the products cheaper for farmers, said a person familiar with the matter. The company also wants to make the most of the booming Hong Kong stock market before it cools, the person added, while recently appointed CEO Hengde Qin, a Chinese national, is seen as a person who can navigate the various approval processes. "We do not comment on market speculation," Syngenta said in a response to Reuters. Sinochem did not respond to a request for comment. Bloomberg News first reported on the filing on Tuesday, saying the company is considering raising about $5 billion. The planned listing would revive an effort by Sinochem to take Syngenta public after the company withdrew a planned Shanghai listing in 2024. Syngenta sells seeds and crop-protection products, including herbicides, insecticides and fungicides, and also provides biological and digital farming products. It has more than 50,000 employees in over 90 countries, according to its website. Syngenta reported a decline in second-quarter sales and profit following its exit from a low-margin business in China. Quarterly sales fell by 7% to $5.7 billion, while earnings before interest, taxes, depreciation and amortisation (EBITDA) dropped 2% to $1 billion. On a currency-adjusted basis, EBITDA was 4% higher. Syngenta in July appointed Qin, previously chief operating officer, as its new CEO, effective August 1, to succeed Jeff Rowe, who returned to the United States after nearly 10 years with the company.

Syngenta files for Hong Kong IPO, aiming to raise at least $5 billion, sources say. By Reuters Reuters Updated September 15, 2026 1:31 PM Gift Article Sept 15 (Reuters) - Swiss seeds and agrichemicals company Syngenta Group has confidentially filed for a Hong Kong initial public offering, aiming to raise at least $5 billion, according to three people with direct knowledge of the matter. The Basel-based company, controlled by Chinese state-owned Sinochem, hopes to launch the offering as soon as the end of this year, or if not, early 2027, said two of the sources. Depending on the market response, the offering size could be up to $10 billion, the sources said. At that size, it would be Hong Kong's biggest IPO since 2010, according to LSEG data. Hong Kong's IPO market is booming, with initial public offerings and secondary listings raising $45.8 billion so far this year, compared with $24 billion in the same period last year, LSEG data showed. The exact timing, offering size and the company's valuation have not been finalised, said the sources, who declined to be named as the information was not public. A listing of that size would test investor appetite for a company whose owner, Sinochem, paid $43 billion to take it private in 2017 and has yet to mark that investment to a public market valuation. Success would hand Hong Kong one of its marquee deals of the year and give Syngenta a way to start paying down some of its debts and also invest in new crop-protection products and seeds. Syngenta expects the global agricultural market to improve next year, especially if there is a resolution in the Iran conflict that would ease shortages of natural gas used to make fertilisers, making the products cheaper for farmers, said a person familiar with the matter. The company also wants to make the most of the booming Hong Kong stock market before it cools, the person added, while recently appointed CEO Hengde Qin, a Chinese national, is seen as a person who can navigate the various approval processes. "We do not comment on market speculation," Syngenta said in a response to Reuters. Sinochem did not respond to a request for comment. Bloomberg News first reported on the filing on Tuesday, saying the company is considering raising about $5 billion. The planned listing would revive an effort by Sinochem to take Syngenta public after the company withdrew a planned Shanghai listing in 2024. SEEDS AND CROP-PROTECTION BUSINESS Syngenta sells seeds and crop-protection products, including herbicides, insecticides and fungicides, and also provides biological and digital farming products. It has more than 50,000 employees in over 90 countries, according to its website. Syngenta reported a decline in second-quarter sales and profit following its exit from a low-margin business in China. Quarterly sales fell by 7% to $5.7 billion, while earnings before interest, taxes, depreciation and amortisation (EBITDA) dropped 2% to $1 billion. On a currency-adjusted basis, EBITDA was 4% higher. Syngenta in July appointed Qin, previously chief operating officer, as its new CEO, effective August 1, to succeed Jeff Rowe, who returned to the United States after nearly 10 years with the company. (Reporting by Bipasha Dey in Bengaluru, Yantoultra Ngui and Kane Wu in Hong Kong and John Revill in Zurich; Additional reporting by Dave Graham in Zurich; Editing by Mrigank Dhaniwala, Susan Fenton and Matthew Lewis) This story was originally published September 14, 2026 at 9:25 PM.